InvestorsHub Logo
Followers 38
Posts 5557
Boards Moderated 0
Alias Born 02/25/2011

Re: None

Thursday, 09/26/2013 9:41:52 AM

Thursday, September 26, 2013 9:41:52 AM

Post# of 427276
My ADCOM submission accepted
This is what I just got back

------------------

Thank you for your written submission and article. These items will be placed (in redacted form) in a binder outside the meeting room for public viewing on the meeting day and also mailed to the committee prior to the meeting.



Regards,



Stephanie Begansky, PharmD

LCDR, USPHS

Designated Federal Officer

Food and Drug Administration (FDA)

Center for Drug Evaluation and Research (CDER)

Office of Executive Programs (OEP)

Division of Advisory Committee and Consultant Management (DACCM)

White Oak Building 31, Room 2426

10903 New Hampshire Avenue

Silver Spring, MD 20993

Main Telephone: (301) 796-9001 and 9002

Office: (301) 796-3693

Fax: (301) 796-8533

Email: Stephanie.Begansky@fda.hhs.gov




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News